Upstream Bio (UPB) Cash from Operations (2023 - 2026)

Upstream Bio's Cash from Operations history runs 4 years deep, the most recent figure standing at 47852000.0 for Q1 2026.

• In Q1 2026, Cash from Operations fell 16.24% year-over-year to 47852000.0; the TTM figure through Mar 2026 stood at 139962000.0 (down 69.09% YoY), while the FY2025 annual figure was 133275000.0, down 125.23% from the prior year.
• Cash from Operations was 47852000.0 for Q1 2026 at Upstream Bio, down from 30631000.0 in the prior quarter.
• In the past five years, Cash from Operations ranged from a high of 8036000.0 in Q2 2024 to a low of 47852000.0 in Q1 2026.
• Historically, Cash from Operations has averaged 25640900.0 across 4 years, with a median of 20926000.0 in 2024.
• The sharpest annual moves came in 2025 and 2026: Cash from Operations plunged 388.29% in 2025, then retreated 16.24% in 2026.
• A 4-year view of Cash from Operations shows it stood at 16110000.0 in 2023, then fell by 21.74% to 19612000.0 in 2024, then tumbled by 56.18% to 30631000.0 in 2025, then plunged by 56.22% to 47852000.0 in 2026.
• The last three Cash from Operations figures came in at 47852000.0 (Q1 2026), 30631000.0 (Q4 2025), and 22240000.0 (Q3 2025), per Business Quant data.